Person: DANSUK, RAMAZAN
28 results
Search Results
Now showing 1 - 10 of 28
Publication Metadata only Granulosa cell tumor presenting with ovarian torsion and de novo borderline mucinous ovarian tumor in the contralateral ovary.(2015-01-01) ATES, SEDA; Sevket, OSMAN; SUDOLMUS, S; SONMEZ, FATMA CAVİDE; DANSUK, RAMAZAN; ATEŞ, SEDA; ŞEVKET, OSMAN; SÖNMEZ, FATMA CAVİDE; DANSUK, RAMAZANPublication Metadata only The use of HbA1c as an aid in the diagnosis of gestational diabetes mellitus.(2014-11-01) Sevket, OSMAN; SEVKET, A; OZEL, A; DANSUK, RAMAZAN; KELEKCI, S; ŞEVKET, OSMAN; DANSUK, RAMAZANPublication Open Access Can CA-125 Predict Lymph Node Metastasis in Epithelial Ovarian Cancers in Turkish Population?(2014-01-01T00:00:00Z) Sudolmus, Sinem; Koroglu, Nadiye; Yildirim, Gokhan; Ulker, Volkan; Gulkilik, Ahmet; DANSUK, RAMAZAN; DANSUK, RAMAZANObjective. The role of single preoperative serum CA-125 levels in predicting pelvic or paraaortic lymph node metastasis in patients operated for epithelial ovarian cancer has been investigated. Methods. 176 patients diagnosed with epithelial ovarian carcinoma after staging laparotomy between January 2002 and May 2010 were evaluated retrospectively. Results. The mean, geometric mean, and median of preoperative serum CA-125 levels were 632,6, 200,29, and 191,5 U/mL, respectively. The cut-off value predicting lymph node metastases in the ROC curve was 71,92 U/mL, which is significant in logistic regression analysis (P = 0.005). The preoperative log CA-125 levels were also statistically significant in predicting lymph node metastasis in logistic regression analysis (P = 0.008). Conclusions. The tumor marker CA-125, which increases with grade independent of the effect of stage in EOC, is predictive of lymph node metastasis with a high rate of false positivity in Turkish population. The high false positive rate may obscure the predictive value of CA-125.Publication Metadata only Minimal invasive approaches in the management of cervical pregnancy Servikal Gebelik Yönetiminde Minimal İnvaziv Yaklaşım(2015-01-01) BATMAZ, Gonca; MOLLA, Fulya; MOLLA, Taner; AYDIN, SERDAR; Dansuk, RAMAZAN; AYDIN, SERDAR; DANSUK, RAMAZANPublication Metadata only Thel Incidence of Concomitant Precancerous Lesions in Cases Who Underwent Hysterectomy for Prolapse(2016-09-01T00:00:00Z) AYDIN, SERDAR; BAKAR, Rabia Zehra; Mammadzade, Aygun; DANSUK, RAMAZAN; AYDIN, SERDAR; BAKAR, RABIA ZEHRA; DANSUK, RAMAZANThe aim of the study was is to assess the incidence of unexpected gynecological cancers and pre-cancerous lesions following hysterectomy for pelvic organ prolapse to better understand the risks of uterine sparing surgery. Material and Method: This was a retrospective analysis of histopathology findings after hysterectomy for uterine prolapse surgery who underwent preoperative diagnostic work including cervical cytology, transvaginal ultrasonography and endometrial histopathological examination for a high risk group (Postmenopausal women with an endometrial thickness of >= 5 mm and premenopausal women with abnormal bleeding). Patients with a history of endometrial, cervical and/or adnexal precancerous or cancerous pathological conditions and with incomplete medical records were excluded. Results: Results were taken from 106 women who underwent hysterectomy. The abdominal route was used in 22 cases (21.7 %), the vaginal route in 82 patients (77.4 %) and laparoscopic-assisted vaginal route in two (1.9 %) women. Oophorectomy was performed in 35 (33 %) cases. None of the patients had malignant histopathology specimens from hysterectomy. Total premalignant pathology incidence was 7.5 % (8/106). Six (5.7%) patients had simple endometrial hyperplasia and 2 patients (1.9 %) had cervical intraepithelial neoplasia. Discussion: The incidence of unexpected endometrial, cervical or ovarian malignancy among women who underwent hysterectomy after preoperative diagnostic workup including transvaginal ultrasonograhy, endometrial pathological examination to high risk cases was negligible. The inclusion of low risk endometrial and cervical precancerous lesions increased the incidences. Our results could provide precious data to extrapolate to similar populations with uterine prolapse who desire surgical correction sparing uterus.Publication Metadata only Olgu sunumu: İzole tuba torsiyonu(2013-05-19) KILIC, GÖKHAN; Sarıoğlu, Aslı Elif; Şevket, OSMAN; Dane, Banu; Dansuk, RAMAZAN; KILIC, GÖKHAN; ŞEVKET, OSMAN; DANSUK, RAMAZANPublication Open Access Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.(2015-06-01) DANSUK, RAMAZAN; GONENC, AI; SUDOLMUS, S; YUCEL, O; Sevket, OSMAN; KÖROĞLU, N; DANSUK, RAMAZAN; ŞEVKET, OSMANIntroduction: Intrauterine insemination (IUI) after controlled ovarian hyperstimulation (COH) was applied to selected infertile patients to determine the effect of gonadotropin-releasing hormone (GnRH) antagonists in IUI cycles, in which recombinant follicle-stimulating hormone (rFSH) had been used for COH. Methods: This study was conducted between April 1, 2009 and June 10, 2009, and involved a total of 108 patients. These patients had primary or secondary infertility, which resulted in an indication for IUI, and they each received two cycles of ovarian stimulation treatment with clomiphene citrate. The patients were randomised into two groups--patients in group A received rFSH + GnRH antagonist (n = 45), while those in group B received only rFSH (n = 63). Results: The mean age of the patients was 31.84 ± 3.73 years and the mean body mass index (BMI) was 24.40 ± 1.88 kg/m(2). The mean age and BMI of the patients in groups A and B were not significantly different. There was no significant difference in the mean total rFSH dose administered (988.33 IU in group A and 871.83 IU in group B). When compared to group B, the mean number of follicles that were > 16 mm on the human chorionic gonadotropin (HCG) trigger day was significantly higher in group A (1.58 and 1.86, respectively; p < 0.05). When the two groups were compared, there were no statistically significant differences in the number of cancelled cycles due to premature luteinisation (none in group A vs. two in group B) and the rate of clinical pregnancy (8.9% in group A vs. 7.9% in group B). Conclusion: No significant improvement in the clinical pregnancy rates was observed when GnRH antagonists were used in COH + IUI cycles, despite the significant increase in the number of follicles that were > 16 mm on HCG trigger day.Publication Metadata only Is methotrexate administration needed for the treatment of caesarean section scar pregnancy in addition to suction curettage?(2014-04-01) Sevket, OSMAN; KESKIN, S; ATES, SEDA; MOLLA, T; DANSUK, RAMAZAN; YAZıCıOĞLU, HF; YUCEL, O; ŞEVKET, OSMAN; ATEŞ, SEDA; DANSUK, RAMAZANPublication Metadata only Is procidentia a distinct disease Comparison of risk factors(2016-05-21T00:00:00Z) AYDIN, SERDAR; KILIÇ, GÖKHAN; DANSUK, RAMAZAN; GÖKMEN KARASU, AYŞE FİLİZ; AYDIN, SERDAR; KILIC, GÖKHAN; DANSUK, RAMAZAN; GÖKMEN KARASU, AYŞE FİLİZPublication Metadata only Effect of vaginal electrical stimulation on female sexual functions: a randomized study.(2015-02-01) Aydın, SERDAR; Arıoğlu, Aydın; BATMAZ, G; Dansuk, RAMAZAN; AYDIN, SERDAR; DANSUK, RAMAZAN
- «
- 1 (current)
- 2
- 3
- »